• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TZ MEDICAL INC. DUAL SITE EP CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TZ MEDICAL INC. DUAL SITE EP CATHETER; CARDIAC ABLATION PERCUTANEOUS CATHETER Back to Search Results
Model Number 14 POLE
Device Problem Insufficient Information (3190)
Patient Problem Pericardial Effusion (3271)
Event Date 05/16/2014
Event Type  No Answer Provided  
Event Description
During atrial fibrillation ablation, steam pop sound was heard during radio frequency application.The patient subsequently developed a pericardial effusion, which required additional medical intervention and hospitalization.The physician/staff involved in the procedure do not know what caused the problem.All are experienced in this type of procedure and with this equipment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUAL SITE EP CATHETER
Type of Device
CARDIAC ABLATION PERCUTANEOUS CATHETER
Manufacturer (Section D)
TZ MEDICAL INC.
17750 sw upper boons ferry roa
150
protland OR 97224
MDR Report Key3873884
MDR Text Key15363543
Report Number3873884
Device Sequence Number3
Product Code LPB
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Risk Manager
Type of Report Initial
Report Date 05/27/2014
6 Devices were Involved in the Event: 1   2   3   4   5   6  
1 Patient was Involved in the Event
Date FDA Received05/27/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Invalid Data
Device Model Number14 POLE
Device Catalogue NumberCF-D7-AAA-NSDA
Device Lot Number026108
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA05/27/2014
Event Location Hospital
Date Report to Manufacturer06/16/2014
Patient Sequence Number1
Treatment
OTHER
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age76 YR
Patient Weight99
-
-